Placeholder canvas

US Looks At Starting Joint Production Of Johnson & Johnson’s COVID-19 Vaccine In India

Date:

The US is looking at starting joint production of Johnson and Johnson’s single-shot COVID-19 vaccine in India and exploring ways to help manufacturers like Serum Institute of India (SII) to boost production.

Briefing the media, Daniel B Smith, the Charge D’Affaires of the US embassy, said the US was concerned over the havoc wreaked by the raging pandemic in India, not simply because of the humanitarian catastrophe but also due to the fact that it has global implications, PTI reported. Smith also said that the Biden administration was standing with India to deal with this unprecedented crisis.

Asked about possibility of joint production of vaccines, Smith said the setting up of joint productions is a time-consuming process and that the US was looking at how it can engage in ramping up  production.

“Our development finance cooperation is looking at how we can invest so that we can help produce the Johnson and Johnson’s vaccine here in India. And I know that there are some private-sector production talks that are underway from pharmaceutical companies to pharmaceutical companies,” he said.

“We are determined to do all we can as a government to encourage licensing and encourage more production and if there is a need for capital, we will look at what we can provide and whether we can provide assistance,” he said.

He also reiterated that India’s role in COVID-19 vaccine production at the global stage is critical.

“I think we are watching carefully the production levels at the SII and elsewhere. We’ve been in close touch with the SII to try to determine what raw materials we could provide, and assistance that we can provide to help boost production,” he said.

Smith also said that the efficacy of AstraZeneca’s COVID-19 vaccine manufactured at a production facility in Baltimore has not yet been certified by the Food and Drug Administration either for anyone’s use or for export.

Last month, the US had said that it plans to share 60 million doses of AstraZeneca’s vaccine globally as soon as they become available. India expected a significant chunk of the total stockpile.

ALSO READ: COVID-19 LIVE Updates | Bharat Biotech Says Can’t Provide Additional Covaxin Doses To Delhi: Manish Sisodia

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

Gangster-Turned-Politician Mukhtar Ansari Dies Of Cardiac Arrest

Banda: Gangster turned politician Mukhtar Ansari passed away at...

IPL 2024: Rajasthan Royals Defeat Delhi Capitals By 12 Runs

Jaipur: Rajasthan Royals clinched a 12-run win over Delhi...

FTX Founder Sam Bankman-Fried Sentenced To 25 Years In Prison For Fraud

New Delhi: Sam Bankman-Fried, the renowned founder of cryptocurrency...